Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
D000499:Allylamine / Q000633:toxicity*; D000588:Amines / Q000633:toxicity*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D004326:Drinking; D006321:Heart / Q000187:drug effects*; D006830:Hydralazine / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008297:Male; D008995:Monoamine Oxidase / Q000032:analysis*; D008996:Monoamine Oxidase Inhibitors / Q000633:toxicity; D009206:Myocardium / Q000201:enzymology / Q000473:pathology; D051381:Rats; D012663:Semicarbazides / Q000494:pharmacology*
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D012663:Semicarbazides; D006830:Hydralazine; D000499:Allylamine; D008995:Monoamine Oxidase